Biopharmaceuticals
-10%
portes grátis
Biopharmaceuticals
Challenges and Opportunities
Behera, Basanta
Taylor & Francis Inc
12/2020
278
Dura
Inglês
9780815347774
15 a 20 dias
453
Descrição não disponível.
Biopharmaceutical- A New Confront. Biopharmaceutical Production. Transitioning from Pharmaceutical to Biopharmaceutical. Biopharmaceutical from Animal cells. Plant Biomolecules and Therapeutic. Biosimilar. Biopharmaceutical Supply Chain Management.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Biologic Drug;Biologic drugs;Biopharmaceutical Companies;3D bioprinting technology;Therapeutic Proteins;Cell culture;Biopharmaceutical Industry;Biosimilars;Foreign DNA;Biopharmaceuticals;Therapeutic Biomolecules;Biosimilars Market;Biosimilar Product;Biosimilars Approved;BPCI Act;Reference Medicine;mAb Biosimilars;Chloroplast DNA Sequence;Target Therapeutic Proteins;HSCT;Animal Cell Culture;LG Life Science;CDSCO;Chloroplast DNA;Cp DNA;Transgenic Plants;Stem Cells;MSCs;Velaglucerase Alfa;Reference Product
Biopharmaceutical- A New Confront. Biopharmaceutical Production. Transitioning from Pharmaceutical to Biopharmaceutical. Biopharmaceutical from Animal cells. Plant Biomolecules and Therapeutic. Biosimilar. Biopharmaceutical Supply Chain Management.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Biologic Drug;Biologic drugs;Biopharmaceutical Companies;3D bioprinting technology;Therapeutic Proteins;Cell culture;Biopharmaceutical Industry;Biosimilars;Foreign DNA;Biopharmaceuticals;Therapeutic Biomolecules;Biosimilars Market;Biosimilar Product;Biosimilars Approved;BPCI Act;Reference Medicine;mAb Biosimilars;Chloroplast DNA Sequence;Target Therapeutic Proteins;HSCT;Animal Cell Culture;LG Life Science;CDSCO;Chloroplast DNA;Cp DNA;Transgenic Plants;Stem Cells;MSCs;Velaglucerase Alfa;Reference Product
